| Title | Withdrawal of Approval of Drug Application: Takeda Pharmaceuticals U.S.A., Inc., Exkivity (Mobocertinib Succinate) Capsule, Equivalent to 40 Milligrams Base |
| ToC Doc | Takeda Pharmaceuticals U.S.A., Inc., Exkivity (Mobocertinib Succinate) Capsule, Equivalent to 40 Milligrams Base |
| Docket Number | 2024-15371 |
| Type | Notice |
| Subject | Withdrawal of Approval of Drug Application: Takeda Pharmaceuticals U.S.A., Inc., Exkivity (Mobocertinib Succinate) Capsule, Equivalent to 40 Milligrams Base |
| Publication Date | 2024-07-15 |
| Last Updated Date | 2024-07-12 08:19:16 -0400 |
| Last Public Inspection | 2024-07-12 |
| Filed At | 2024-07-12T08:45:00.000-04:00 |
| 2024-15371_PI.pdf (95346 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 2 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...